NO141754C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aryloksyaminobutanoler - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive aryloksyaminobutanolerInfo
- Publication number
- NO141754C NO141754C NO750566A NO750566A NO141754C NO 141754 C NO141754 C NO 141754C NO 750566 A NO750566 A NO 750566A NO 750566 A NO750566 A NO 750566A NO 141754 C NO141754 C NO 141754C
- Authority
- NO
- Norway
- Prior art keywords
- aryloxyaminobutanols
- preparation
- therapeutic active
- analogy procedure
- analogy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUCI1449A HU169464B (pl) | 1974-02-20 | 1974-02-20 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO750566L NO750566L (pl) | 1975-08-21 |
NO141754B NO141754B (no) | 1980-01-28 |
NO141754C true NO141754C (no) | 1980-05-07 |
Family
ID=10994508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO750566A NO141754C (no) | 1974-02-20 | 1975-02-19 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive aryloksyaminobutanoler |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS5929063B2 (pl) |
AT (1) | AT339281B (pl) |
BE (1) | BE825745A (pl) |
BG (2) | BG26366A3 (pl) |
CA (1) | CA1074338A (pl) |
CH (1) | CH619684A5 (pl) |
CS (1) | CS199578B2 (pl) |
DD (1) | DD119414A5 (pl) |
DE (1) | DE2506355C2 (pl) |
DK (1) | DK141935B (pl) |
ES (2) | ES434784A1 (pl) |
FI (1) | FI61304C (pl) |
FR (1) | FR2261001B1 (pl) |
GB (1) | GB1457086A (pl) |
HU (1) | HU169464B (pl) |
IL (1) | IL46634A (pl) |
NL (1) | NL182698C (pl) |
NO (1) | NO141754C (pl) |
PL (2) | PL99025B1 (pl) |
SE (1) | SE433935B (pl) |
SU (1) | SU1025327A3 (pl) |
YU (2) | YU36916B (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL48309A (en) * | 1974-10-25 | 1980-01-31 | Robins Co Inc A H | 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them |
EP0097000B1 (en) * | 1982-06-10 | 1987-09-09 | Beecham Wuelfing GmbH & Co KG | Amine derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE368197B (pl) * | 1968-11-18 | 1974-06-24 | Pfizer | |
GB1245148A (en) * | 1968-11-18 | 1971-09-08 | Pfizer Ltd | Propanolamine derivatives |
SE384853B (sv) * | 1972-04-04 | 1976-05-24 | Haessle Ab | Forfarande for framstellning av nya aminer |
AT305245B (de) * | 1969-09-24 | 1973-02-12 | Ici Ltd | Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen |
-
1974
- 1974-02-20 HU HUCI1449A patent/HU169464B/hu unknown
-
1975
- 1975-02-14 IL IL46634A patent/IL46634A/xx unknown
- 1975-02-14 DE DE2506355A patent/DE2506355C2/de not_active Expired
- 1975-02-17 AT AT114075A patent/AT339281B/de not_active IP Right Cessation
- 1975-02-17 ES ES434784A patent/ES434784A1/es not_active Expired
- 1975-02-17 DD DD184260A patent/DD119414A5/xx unknown
- 1975-02-18 FI FI750443A patent/FI61304C/fi not_active IP Right Cessation
- 1975-02-18 BG BG029004A patent/BG26366A3/xx not_active Expired
- 1975-02-18 YU YU0373/75A patent/YU36916B/xx unknown
- 1975-02-18 FR FR7504961A patent/FR2261001B1/fr not_active Expired
- 1975-02-18 BG BG030300A patent/BG26367A4/xx unknown
- 1975-02-18 SE SE7501801A patent/SE433935B/xx not_active IP Right Cessation
- 1975-02-19 NO NO750566A patent/NO141754C/no unknown
- 1975-02-19 NL NLAANVRAGE7501951,A patent/NL182698C/xx not_active IP Right Cessation
- 1975-02-19 CA CA220,429A patent/CA1074338A/en not_active Expired
- 1975-02-19 GB GB705075A patent/GB1457086A/en not_active Expired
- 1975-02-19 PL PL1975193962A patent/PL99025B1/pl unknown
- 1975-02-19 PL PL1975178154A patent/PL99023B1/pl unknown
- 1975-02-19 CH CH206475A patent/CH619684A5/de not_active IP Right Cessation
- 1975-02-19 SU SU752108001A patent/SU1025327A3/ru active
- 1975-02-19 DK DK60875AA patent/DK141935B/da not_active IP Right Cessation
- 1975-02-20 CS CS751129A patent/CS199578B2/cs unknown
- 1975-02-20 BE BE153530A patent/BE825745A/xx not_active IP Right Cessation
- 1975-02-20 JP JP50020452A patent/JPS5929063B2/ja not_active Expired
-
1976
- 1976-11-15 ES ES453326A patent/ES453326A1/es not_active Expired
-
1981
- 1981-07-08 YU YU1676/81A patent/YU37116B/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO143576C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser | |
NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
NO145691C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider | |
NO149106C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider | |
NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
NO147109C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater | |
NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
NO141894C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner | |
NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
NO146060C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol | |
NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
NO144704C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler | |
NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
NO144110C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater | |
NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater | |
NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
NO144741C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler |